Desk›Healthcare› Viyash Scientific Ltd
Viyash Scientific Ltd
BSE 512529 · NSE VIYASH · ISIN INE807F01027 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹260.00
-1.23%
BSE close, 28 August 2026
₹11,410.80 cr
43.9 cr shares · Small cap
₹4,069.24 cr
as published
189.8× · 10.24×
EPS ₹1.37 · BV ₹25.39
1,382.06 / 75.87
₹ cr, as filed
21
5 selected · 24%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -12.7% |
|---|---|
| Against 52-week low | +55.2% |
| Day change | -1.23% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹1.37 |
|---|---|
| Price / earnings | 189.78× |
| Price / book | 10.24× |
| Book value — derived, price ÷ P/B | ₹25.39 |
| Return on equity | 5.39% |
| Operating margin | 17.46% |
| Net margin | 5.91% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 5.40%
- ROE as published
- 5.39%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 353.69 | 20.92 | 0.48 | 17.46% | 5.91% |
| Mar-26 · Q | 372.49 | 35.81 | 0.82 | 22.13% | 9.61% |
| FY25-26 | 1,382.06 | 75.87 | 1.75 | 18.57% | 5.49% |
Quarter on quarter
- Revenue, quarter on quarter
- -5.0%
- Net profit, quarter on quarter
- -41.6%
- Operating margin, quarter on quarter
- -467 bps
Disclosure profile 21 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Acquisition | 1 |
| Board Outcome | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| ESOP Allotment | 4 |
| AGM / EGM | 3 |
| Analyst / Investor Meet | 2 |
| General | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Newspaper Publication | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 16 |
| Total | 21 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
21 filings · 5 selected · busiest 2026-08-11
Filing rhythm · the twelve most recent
2026-08-112026-10-08
SelectedProcedural
Filings
21 in the window · 14 earlier on record
-
8 October 2026 ·
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Re. 74(5) of SEBI (DP) Regulation is enclosed.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
1 October 2026 ·
Updates on Acquisition
Completion of acquisition of BioForLife Italia S.r.l.
Company Update / Acquisition View filing →
-
28 September 2026 ·
Closure of Trading Window
Closure of Trading Window for Q2 FY 2026-27
Insider Trading / SAST / Closure of Trading Window View filing →
-
18 September 2026 ·
-
8 September 2026 ·
Update On Proposed Acquisition Of Bioforlife Italia S.R.L
Update on proposed acquisition of BioForLife Italia S.r.l
Company Update / General View filing →
-
4 September 2026 ·
-
27 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CA Harbor Investment & CA Hull Investments
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
12 August 2026 ·
Analyst / Investor Meet - Outcome
Audio Recording of Earnings call pertaining to the unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30, 2026
Company Update / Analyst / Investor Meet View filing →
-
12 August 2026 ·
Newspaper Publication
Newspaper Publication for Financial Results of Q1 FY 27.
Company Update / Newspaper Publication View filing →
-
12 August 2026 ·
Investor Presentation
Investor Presentation Q1 FY 2026-2027
Company Update / Investor Presentation View filing →
-
11 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting results and scrutinizer Report
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting results and scrutinizer Report
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of the 41st AGM held on August 11, 2026
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Press Release / Media Release
Press Release for Q1 FY 2026-27
Company Update / Press Release / Media Release View filing →
-
11 August 2026 ·
Allotment of ESOP / ESPS
Allotment of ESOP under Viyash Scientific Limited -Employee Stock Option Scheme 2026
Company Update / Allotment of ESOP / ESPS View filing →
-
11 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
11 August 2026 ·
Unaudited Financial Results For Q1 FY 2026-2027
Unaudited Financial Results for Q1 FY 2026-2027
Result / Financial Results View filing →
-
3 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Q1 FY27 Earnings Conference Call / Discussion on Financial Results for Quarter Ended June 30, 2026
Company Update / Analyst / Investor Meet View filing →
-
3 August 2026 ·
Board Meeting Intimation for Quarterly Results For Q1 FY 2026-27
Viyash Scientific Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Quarterly Results for Q1 FY 2026-27
Board Meeting / Board Meeting View filing →
-
21 July 2026 ·
Intimation Under Regulation 30 Of SEBI LODR
Intimation under Regulation 30 of SEBI LODR
Company Update / General View filing →
RSS feed for Viyash Scientific Ltd · the 50 most recent filings